Adenine Nucleotide Translocase 1 Deficiency Results in Dilated Cardiomyopathy With Defects in Myocardial Mechanics, Histopathological Alterations, and Activation of Apoptosis

Center for Mitochondrial and Molecular Medicine and Genetics (MAMMAG), University of California, Irvine, California, USA.
JACC. Cardiovascular imaging (Impact Factor: 7.19). 01/2011; 4(1):1-10. DOI: 10.1016/j.jcmg.2010.06.018
Source: PubMed


the aim of this study was to test the hypothesis that chronic mitochondrial energy deficiency causes dilated cardiomyopathy, we characterized the hearts of age-matched young and old adenine nucleotide translocator (ANT)1 mutant and control mice.
ANTs export mitochondrial adenosine triphosphate into the cytosol and have a role in the regulation of the intrinsic apoptosis pathway. Mitochondrial energy deficiency has been hypothesized, on the basis of indirect evidence, to be a factor in the pathophysiology of dilated cardiomyopathies. Ant1 inactivation should limit adenosine triphosphate for contraction and calcium transport, thereby resulting in early cardiac dysfunction with later dilation and heart failure.
we conducted a multiyear study of 73 mutant (Ant1-/-) and 57 control (Ant1+/+) mice, between the ages of 2 and 21 months. Hearts were characterized by cardiac anatomy, echocardiographic imaging with velocity vector analysis, histopathology, and apoptosis assays.
the Ant1-/- mice developed a distinctive concentric dilated cardiomyopathy, characterized by substantial myocardial hypertrophy and ventricular dilation, with cardiac function declining earlier in age as compared to control mice. Left ventricular circumferential, radial, and rotational mechanics were reduced even in the younger mutants with preserved systolic function. Histopathologic analysis demonstrated increased myocyte hypertrophy, fibrosis, and calcification in the mutant mice as compared with control mice. Furthermore, increased cytoplasmic cytochrome c levels and caspase 3 activation were observed in the mutant mice.
our results demonstrate that mitochondrial energy deficiency is sufficient to cause dilated cardiomyopathy, confirming that energy defects are a factor in this disease. Energy deficiency initially leads to early mechanical dysfunction before a decline in left ventricular systolic function. Chronic energy deficiency with age then leads to heart failure. Our results now allow us to use the Ant1-/- mouse model for testing new therapies for ANT1 mutant patients.

Download full-text


Available from: Partho P Sengupta
  • Source
    • "However, these studies have certain limitations; in human cells, the ability to recapitulate the exact in vivo physiological conditions in affected tissues – for example, the failing heart – is severely limited. As indicated above, Ant1-knockout mice exhibit dilated cardiomyopathy that is associated with a progressive decline of cardiac functions, ending in chronic heart failure (Narula et al., 2011). Conversely, Ant1 overexpression is cardioprotective (Wang et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A point mutation (stress-sensitive B(1), sesB(1) in the Drosophila gene coding for the major adult isoform of the adenine nuclear translocase (ANT) represents a model for human diseases associated with ANT insufficiency. We characterized the organismal, bioenergetic and molecular phenotype of sesB(1), then tested strategies to compensate the mutant phenotype. In addition to developmental delay and bang-sensitivity, sesB(1) manifests impaired response to sound, defective male courtship, female sterility and curtailed lifespan. These phenotypes, apart from the last two, are shared with the tko(25t) mutant in mitoribosomal protein S12. Mitochondria from sesB(1) adults showed a decreased respiratory control ratio and downregulation of cytochrome oxidase. sesB(1) adults exhibited ATP depletion, lactate accumulation, and changes in gene expression consistent with a metabolic shift towards glycolysis, with activation of lactate dehydrogenase and anaplerotic pathways. Females also showed downregulation of many genes required for oogenesis, and their eggs, though fertilized, failed to develop to the larval stages. The sesB(1) phenotypes of developmental delay and bang-sensitivity were alleviated by altered mtDNA background. Female sterility was substantially rescued by somatic expression of the alternative oxidase (AOX) from Ciona intestinalis, whereas AOX did not alleviate developmental delay. Our findings illustrate the potential of different therapeutic strategies for ANT-linked diseases, based on increasing mitochondrial bioenergy production, or on alleviating metabolic stress.
    Full-text · Article · May 2014 · Disease Models and Mechanisms
  • Source
    • "Hypertrophy and cardiac failure has often been associated with mitochondrial dysfunction and oxidative stress [26], [27], [28]. Mitochondrial energy deficiency is known to underlie dilated cardiomyopathy characterized by early mechanical dysfunction followed by a decline in left ventricular systolic function [29]. We therefore wanted to determine the redox and mitochondrial health of the Dicer depleted hearts. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dicer endonuclease, critical for maturation of miRNAs, is depleted in certain forms of cardiomyopathy which results in differential expression of certain microRNAs. We sought to elucidate the mechanisms underlying the rapid loss of cardiac function following cardiac-specific Dicer depletion in adult mice. Conditional Dicer deletion in the adult murine myocardium demonstrated compromised heart function, mitochondrial dysfunction and oxidant stress. Elevated miR-15b was observed as an early response to Dicer depletion and was found to silence Pim-1 kinase, a protein responsible for maintaining mitochondrial integrity and function. Anti-miRNA based suppression of induced miRNA-15b rescued the function of Dicer-depleted adult heart and attenuated hypertrophy. Anti-miRNA based suppression of inducible miRNA-15b can prevent rapid loss of cardiac function in a Dicer-depleted adult heart and can be a key approach worthy of therapeutic consideration.
    Full-text · Article · Jun 2013 · PLoS ONE
  • Source
    • "Due primarily to phenotypic rarity, data are lacking concerning natural history in patients with mtDNA disease and DCM phenotype. Mouse models of DCM and mitochondrial disease do exist, 39,53,54 but do not feature mtDNA point mutations or single deletions and have little direct relevance to patients with these specific mutations. Cardiac symptoms may be limited in patients with multisystem mtDNA disease due to progressive skeletal myopathy restricting physical activity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial disease refers to a heterogenous group of genetic disorders that result from dysfunction of the final common pathway of energy metabolism. Mitochondrial DNA mutations affect key components of the respiratory chain and account for the majority of mitochondrial disease in adults. Owing to critical dependence of the heart on oxidative metabolism, cardiac involvement in mitochondrial disease is common and may occur as the principal clinical manifestation or part of multisystem disease. Recent advances in our understanding of the clinical spectrum and genetic aetiology of cardiac involvement in mitochondrial DNA disease have important implications for cardiologists in terms of the investigation and multi-disciplinary management of patients.
    Full-text · Article · Aug 2012 · European Heart Journal
Show more